EP Patent

EP2329857A1 — A drug delivery device

Assigned to Sanofi Aventis Deutschland GmbH · Expires 2011-06-08 · 15y expired

What this patent protects

A drug delivery device comprises a housing (2) and a piston rod (13) arranged in the housing. The piston rod (13) is adapted to be moved along an axial direction to dispense a fluid. A drive member (5) arranged in the housing (2) is operatively coupled to the piston rod (13) and …

USPTO Abstract

A drug delivery device comprises a housing (2) and a piston rod (13) arranged in the housing. The piston rod (13) is adapted to be moved along an axial direction to dispense a fluid. A drive member (5) arranged in the housing (2) is operatively coupled to the piston rod (13) and adapted to set up a dose of fluid for dispense in response to a first movement. The drive member (5) is also adapted to move the piston rod (13) to dispense the dose in response to a second movement. The drug delivery device also comprises a pre-dispensing drive member (18) operatively coupled to the drive member (5) and the housing (2) and adapted to move at least the drive member (5) by a pre-dispensing distance between its first and second movement.

Drugs covered by this patent

Patent Metadata

Patent number
EP2329857A1
Jurisdiction
EP
Classification
Expires
2011-06-08
Drug substance claim
No
Drug product claim
No
Assignee
Sanofi Aventis Deutschland GmbH
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.